PBSCs from unrelated donors associated with higher rates of chronic GVHD
HemOncToday
While PBSCs from related donors have been shown to have clinical benefit, Anasetti told HemOnc Today that these results show that PSBCs from unrelated donors put patients at greater risk for chronic GVHD without conferring similar benefits. ...
PBSC Transplants from Unrelated Donors Show No Survival AdvantageThe Oncology Report
ASH: Bone Marrow Best for Unrelated Donor SCTMedPage Today

all 5 news articles »